Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Web-Based Measure of Life Events Using Computerized Life Events and Assessment Record (CLEAR): Preliminary Cross-Sectional Study of Reliability, Validity, and Association With Depression.

Bifulco A, Spence R, Nunn S, Kagan L, Bailey-Rodriguez D, Hosang GM, Taylor M, Fisher HL.

JMIR Ment Health. 2019 Jan 8;6(1):e10675. doi: 10.2196/10675.

2.

Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system.

Lee JB, Zgair A, Malec J, Kim TH, Kim MG, Ali J, Qin C, Feng W, Chiang M, Gao X, Voronin G, Garces AE, Lau CL, Chan TH, Hume A, McIntosh TM, Soukarieh F, Al-Hayali M, Cipolla E, Collins HM, Heery DM, Shin BS, Yoo SD, Kagan L, Stocks MJ, Bradshaw TD, Fischer PM, Gershkovich P.

J Control Release. 2018 Sep 28;286:10-19. doi: 10.1016/j.jconrel.2018.07.022. Epub 2018 Jul 18.

3.

Physiologically-based modeling and interspecies prediction of paclitaxel pharmacokinetics.

Zang X, Kagan L.

J Pharmacokinet Pharmacodyn. 2018 Aug;45(4):577-592. doi: 10.1007/s10928-018-9586-9. Epub 2018 Apr 18.

PMID:
29671170
4.

Evaluation of the Effects of Animal Growth and Previous Exposure on the Pharmacokinetics of Rituximab in Rats.

Chapy H, Kagan L.

J Pharm Sci. 2018 Jul;107(7):1987-1994. doi: 10.1016/j.xphs.2018.03.006. Epub 2018 Mar 15.

PMID:
29551353
5.

Acetylsalicylic Acid Produces Different Effects on the Production of Active Oxygen Species by Activated Platelets in Different Inflammatory Diseases.

Gabbasov ZA, Kogan-Yasny VV, Lakhno DA, Kagan LG, Ryzhkova EV, Vasilieva EY, Shpektor AV.

Bull Exp Biol Med. 2017 Nov;164(1):36-40. doi: 10.1007/s10517-017-3921-9. Epub 2017 Nov 9.

PMID:
29124532
6.

Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease.

Kuo B, Bhasin M, Jacquart J, Scult MA, Slipp L, Riklin EI, Lepoutre V, Comosa N, Norton BA, Dassatti A, Rosenblum J, Thurler AH, Surjanhata BC, Hasheminejad NN, Kagan L, Slawsby E, Rao SR, Macklin EA, Fricchione GL, Benson H, Libermann TA, Korzenik J, Denninger JW.

PLoS One. 2017 Feb 21;12(2):e0172872. doi: 10.1371/journal.pone.0172872. eCollection 2017.

7.

Quantitative analysis of lab-to-lab variability in Caco-2 permeability assays.

Lee JB, Zgair A, Taha DA, Zang X, Kagan L, Kim TH, Kim MG, Yun HY, Fischer PM, Gershkovich P.

Eur J Pharm Biopharm. 2017 May;114:38-42. doi: 10.1016/j.ejpb.2016.12.027. Epub 2017 Jan 12.

PMID:
28088633
8.

The Effectiveness of Low-Level Light Therapy in Attenuating Vocal Fatigue.

Kagan LS, Heaton JT.

J Voice. 2017 May;31(3):384.e15-384.e23. doi: 10.1016/j.jvoice.2016.09.004. Epub 2016 Nov 7.

PMID:
27839705
9.

Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting.

Brunetti L, Sanchez-Catanese B, Kagan L, Wen X, Liu M, Buckley B, Luyendyk JP, Aleksunes LM.

Thromb J. 2016 May 6;14:10. doi: 10.1186/s12959-016-0084-2. eCollection 2016.

10.

Proliposomal Ropivacaine Oil: Pharmacokinetic and Pharmacodynamic Data After Subcutaneous Administration in Volunteers.

Ginosar Y, Haroutounian S, Kagan L, Naveh M, Aharon A, Davidson EM.

Anesth Analg. 2016 May;122(5):1673-80. doi: 10.1213/ANE.0000000000001217.

PMID:
27057798
11.

A Novel Proliposomal Ropivacaine Oil: Pharmacokinetic-Pharmacodynamic Studies After Subcutaneous Administration in Pigs.

Davidson EM, Haroutounian S, Kagan L, Naveh M, Aharon A, Ginosar Y.

Anesth Analg. 2016 May;122(5):1663-72. doi: 10.1213/ANE.0000000000001200.

PMID:
27057797
12.

EXPERIMENTAL SUBSTANTIATION AND CLINICAL APPLICATION OF MICROSURGICAL ANTIREFLUX GASTROINTESTINAL ANASTOMOSES IN GASTRIC RESECTION.

Tretyakov AA, Kagan LI, Schetinin AF, Petrov SV, Neverov AN, Dronowa OB.

Eksp Klin Gastroenterol. 2016;(11):64-68. English, Russian.

PMID:
29889448
13.

Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy.

Brunetti L, Kagan L, Forrester G, Aleksunes LM, Lin H, Buyske S, Nahass RG.

Clin Ther. 2016 Jan 1;38(1):204-10. doi: 10.1016/j.clinthera.2015.11.009. Epub 2015 Dec 11.

14.

Resilient Warrior: A Stress Management Group to Improve Psychological Health in Service Members.

Sylvia LG, Bui E, Baier AL, Mehta DH, Denninger JW, Fricchione GL, Casey A, Kagan L, Park ER, Simon NM.

Glob Adv Health Med. 2015 Nov;4(6):38-42. doi: 10.7453/gahmj.2015.080. Epub 2015 Nov 1.

15.

Measuring Life Events and Their Association With Clinical Disorder: A Protocol for Development of an Online Approach.

Spence R, Bunn A, Nunn S, Hosang GM, Kagan L, Fisher HL, Taylor M, Bifulco A.

JMIR Res Protoc. 2015 Jul 14;4(3):e83. doi: 10.2196/resprot.4085.

16.

Pharmacokinetics and pharmacodynamics of 3,3'-diindolylmethane (DIM) in regulating gene expression of phase II drug metabolizing enzymes.

Wu TY, Huang Y, Zhang C, Su ZY, Boyanapalli S, Khor TO, Wang H, Lin H, Gounder M, Kagan L, Androulakis IP, Kong AN.

J Pharmacokinet Pharmacodyn. 2015 Aug;42(4):401-8. doi: 10.1007/s10928-015-9421-5. Epub 2015 Jul 3.

PMID:
26138223
17.

Genomic and clinical effects associated with a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammatory bowel disease.

Kuo B, Bhasin M, Jacquart J, Scult MA, Slipp L, Riklin EI, Lepoutre V, Comosa N, Norton BA, Dassatti A, Rosenblum J, Thurler AH, Surjanhata BC, Hasheminejad NN, Kagan L, Slawsby E, Rao SR, Macklin EA, Fricchione GL, Benson H, Libermann TA, Korzenik J, Denninger JW.

PLoS One. 2015 Apr 30;10(4):e0123861. doi: 10.1371/journal.pone.0123861. eCollection 2015. Erratum in: PLoS One. 2017 Feb 21;12 (2):e0172872.

18.

Mind-body group treatment for women coping with infertility: a pilot study.

Psaros C, Kagan L, Shifren JL, Willett J, Jacquart J, Alert MD, Macklin EA, Styer AK, Denninger JW, LaRoche KL, Park ER.

J Psychosom Obstet Gynaecol. 2015;36(2):75-83. doi: 10.3109/0167482X.2014.989983. Epub 2014 Dec 26.

PMID:
25541217
19.

Osteoarthritis disease progression model using six year follow-up data from the osteoarthritis initiative.

Passey C, Kimko H, Nandy P, Kagan L.

J Clin Pharmacol. 2015 Mar;55(3):269-78. doi: 10.1002/jcph.399. Epub 2014 Nov 12.

PMID:
25212288
20.

Pharmacokinetic modeling of the subcutaneous absorption of therapeutic proteins.

Kagan L.

Drug Metab Dispos. 2014 Nov;42(11):1890-905. doi: 10.1124/dmd.114.059121. Epub 2014 Aug 13. Review.

21.

Interspecies pharmacokinetic modeling of subcutaneous absorption of rituximab in mice and rats.

Kagan L, Zhao J, Mager DE.

Pharm Res. 2014 Dec;31(12):3265-73. doi: 10.1007/s11095-014-1416-1. Epub 2014 May 23.

22.

Population pharmacodynamic modeling of exenatide after 2-week treatment in STZ/NA diabetic rats.

Chen T, Kagan L, Mager DE.

J Pharm Sci. 2013 Oct;102(10):3844-51. doi: 10.1002/jps.23682. Epub 2013 Jul 29.

23.

Enhanced antinociceptive efficacy of epidural compared with i.v. methadone in a rat model of thermal nociception.

Haroutiunian S, Kagan L, Yifrach-Damari I, Davidson E, Ratz Y, Hoffman A.

Br J Anaesth. 2014 Jan;112(1):150-8. doi: 10.1093/bja/aet234. Epub 2013 Jul 10.

24.

Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition.

Kagan L, Gershkovich P, Wasan KM, Mager DE.

Pharm Res. 2014 Jan;31(1):35-45. doi: 10.1007/s11095-013-1127-z. Epub 2013 Jun 21.

PMID:
23793994
25.

Interspecies modeling and prediction of human exenatide pharmacokinetics.

Chen T, Mager DE, Kagan L.

Pharm Res. 2013 Mar;30(3):751-60. doi: 10.1007/s11095-012-0917-z. Epub 2012 Nov 15.

26.

Mechanisms of subcutaneous absorption of rituximab in rats.

Kagan L, Mager DE.

Drug Metab Dispos. 2013 Jan;41(1):248-55. doi: 10.1124/dmd.112.048496. Epub 2012 Nov 5.

27.

A brief report of depressive symptoms and health promoting behaviors among women with infertility attending a clinical mind-body program.

Psaros C, Kagan L, Auba E, Alert M, Park ER.

J Psychosom Obstet Gynaecol. 2012 Mar;33(1):32-6. doi: 10.3109/0167482X.2011.643933. Epub 2012 Jan 4.

PMID:
22214290
28.

Combustion waves in hydraulically resisted systems.

Brailovsky I, Kagan L, Sivashinsky G.

Philos Trans A Math Phys Eng Sci. 2012 Feb 13;370(1960):625-46. doi: 10.1098/rsta.2011.0341.

PMID:
22213662
29.

Subcutaneous absorption of monoclonal antibodies: role of dose, site of injection, and injection volume on rituximab pharmacokinetics in rats.

Kagan L, Turner MR, Balu-Iyer SV, Mager DE.

Pharm Res. 2012 Feb;29(2):490-9. doi: 10.1007/s11095-011-0578-3. Epub 2011 Sep 2.

PMID:
21887597
30.

TheViral MetaGenome Annotation Pipeline(VMGAP):an automated tool for the functional annotation of viral Metagenomic shotgun sequencing data.

Lorenzi HA, Hoover J, Inman J, Safford T, Murphy S, Kagan L, Williamson SJ.

Stand Genomic Sci. 2011 Jul 1;4(3):418-29. doi: 10.4056/sigs.1694706. Epub 2011 Jun 30.

31.
32.

The JCVI standard operating procedure for annotating prokaryotic metagenomic shotgun sequencing data.

Tanenbaum DM, Goll J, Murphy S, Kumar P, Zafar N, Thiagarajan M, Madupu R, Davidsen T, Kagan L, Kravitz S, Rusch DB, Yooseph S.

Stand Genomic Sci. 2010 Mar 30;2(2):229-37. doi: 10.4056/sigs.651139.

33.

A novel subcutaneous controlled-release amoxicillin degradable implant for extended-interval administration in veterinary medicine.

Horwitz E, Kagan L, Avni-Magen N, Daryi D, Gati I, Hoffman A, Friedman M, Lavy E.

J Vet Pharmacol Ther. 2011 Oct;34(5):494-8. doi: 10.1111/j.1365-2885.2010.01256.x. Epub 2010 Dec 28.

PMID:
21198679
34.

Novel gastroretentive controlled-release drug delivery system for amoxicillin therapy in veterinary medicine.

Horwitz E, Kagan L, Chamisha Y, Gati I, Hoffman A, Friedman M, Lavy E.

J Vet Pharmacol Ther. 2011 Oct;34(5):487-93. doi: 10.1111/j.1365-2885.2010.01255.x. Epub 2010 Dec 28.

PMID:
21198678
35.

Role of p-glycoprotein in region-specific gastrointestinal absorption of talinolol in rats.

Kagan L, Dreifinger T, Mager DE, Hoffman A.

Drug Metab Dispos. 2010 Sep;38(9):1560-6. doi: 10.1124/dmd.110.033019. Epub 2010 Jun 10.

36.

Type I interferon receptor is a primary regulator of target-mediated drug disposition of interferon-beta in mice.

Abraham AK, Kagan L, Kumar S, Mager DE.

J Pharmacol Exp Ther. 2010 Jul;334(1):327-32. doi: 10.1124/jpet.110.167650. Epub 2010 Apr 20.

37.

High-dose bupivacaine remotely loaded into multivesicular liposomes demonstrates slow drug release without systemic toxic plasma concentrations after subcutaneous administration in humans.

Davidson EM, Barenholz Y, Cohen R, Haroutiunian S, Kagan L, Ginosar Y.

Anesth Analg. 2010 Apr 1;110(4):1018-23. doi: 10.1213/ANE.0b013e3181d26d2a.

PMID:
20357145
38.

Interspecies scaling of receptor-mediated pharmacokinetics and pharmacodynamics of type I interferons.

Kagan L, Abraham AK, Harrold JM, Mager DE.

Pharm Res. 2010 May;27(5):920-32. doi: 10.1007/s11095-010-0098-6. Epub 2010 Mar 16.

39.

[A comparative in vitro analysis of primary and immortalized keratocytes].

Kagan L, Rieck PW.

Ophthalmologe. 2010 Apr;107(4):341-6. doi: 10.1007/s00347-009-2003-4. German.

PMID:
19967540
40.

Subcutaneous and intraperitoneal lipogranulomas following subcutaneous injection of olive oil in Sprague-Dawley rats.

Ramot Y, Ben-Eliahu S, Kagan L, Ezov N, Nyska A.

Toxicol Pathol. 2009 Dec;37(7):882-6. doi: 10.1177/0192623309347911.

PMID:
19770348
41.

A novel sustained-release clotrimazole varnish for local treatment of oral candidiasis.

Czerninski R, Sivan S, Steinberg D, Gati I, Kagan L, Friedman M.

Clin Oral Investig. 2010 Feb;14(1):71-8. doi: 10.1007/s00784-009-0275-3. Epub 2009 Apr 29.

PMID:
19404692
42.

Effect of mode of administration on guaifenesin pharmacokinetics and expectorant action in the rat model.

Kagan L, Lavy E, Hoffman A.

Pulm Pharmacol Ther. 2009 Jun;22(3):260-5. doi: 10.1016/j.pupt.2008.12.020. Epub 2009 Jan 6.

PMID:
19166957
43.

Meeting report: the fifth Genomic Standards Consortium (GSC) workshop.

Field D, Garrity GM, Sansone SA, Sterk P, Gray T, Kyrpides N, Hirschman L, Glöckner FO, Kottmann R, Angiuoli S, White O, Dawyndt P, Thomson N, Gil IS, Morrison N, Tatusova T, Mizrachi I, Vaughan R, Cochrane G, Kagan L, Murphy S, Schriml L; Genomic Standards Consortium.

OMICS. 2008 Jun;12(2):109-13. doi: 10.1089/omi.2008.A3B3.

PMID:
18564915
44.

Systems for region selective drug delivery in the gastrointestinal tract: biopharmaceutical considerations.

Kagan L, Hoffman A.

Expert Opin Drug Deliv. 2008 Jun;5(6):681-92. doi: 10.1517/17425247.5.6.681 . Review.

PMID:
18532923
45.

A standard MIGS/MIMS compliant XML Schema: toward the development of the Genomic Contextual Data Markup Language (GCDML).

Kottmann R, Gray T, Murphy S, Kagan L, Kravitz S, Lombardot T, Field D, Glöckner FO; Genomic Standards Consortium.

OMICS. 2008 Jun;12(2):115-21. doi: 10.1089/omi.2008.0A10.

PMID:
18479204
46.

The minimum information about a genome sequence (MIGS) specification.

Field D, Garrity G, Gray T, Morrison N, Selengut J, Sterk P, Tatusova T, Thomson N, Allen MJ, Angiuoli SV, Ashburner M, Axelrod N, Baldauf S, Ballard S, Boore J, Cochrane G, Cole J, Dawyndt P, De Vos P, DePamphilis C, Edwards R, Faruque N, Feldman R, Gilbert J, Gilna P, Glöckner FO, Goldstein P, Guralnick R, Haft D, Hancock D, Hermjakob H, Hertz-Fowler C, Hugenholtz P, Joint I, Kagan L, Kane M, Kennedy J, Kowalchuk G, Kottmann R, Kolker E, Kravitz S, Kyrpides N, Leebens-Mack J, Lewis SE, Li K, Lister AL, Lord P, Maltsev N, Markowitz V, Martiny J, Methe B, Mizrachi I, Moxon R, Nelson K, Parkhill J, Proctor L, White O, Sansone SA, Spiers A, Stevens R, Swift P, Taylor C, Tateno Y, Tett A, Turner S, Ussery D, Vaughan B, Ward N, Whetzel T, San Gil I, Wilson G, Wipat A.

Nat Biotechnol. 2008 May;26(5):541-7. doi: 10.1038/nbt1360.

47.

Easing the transition.

Ferrari N, Kagan L, Kessel B, Benson H.

Newsweek. 2004 Sep 27;144(13):74. No abstract available.

PMID:
18441645
48.
49.

The balancing act: psychiatrists' experience of moral distress.

Austin WJ, Kagan L, Rankel M, Bergum V.

Med Health Care Philos. 2008 Mar;11(1):89-97. Epub 2007 Aug 17.

PMID:
17703374
50.

The role of the lymphatic system in subcutaneous absorption of macromolecules in the rat model.

Kagan L, Gershkovich P, Mendelman A, Amsili S, Ezov N, Hoffman A.

Eur J Pharm Biopharm. 2007 Nov;67(3):759-65. Epub 2007 Apr 7.

PMID:
17499981

Supplemental Content

Support Center